2024.04.10

Foreign Filling Restrictions of Major Countries －Mechanisms to Restrict Foreign Filing of Sensitive Inventions－

2024.01.17

The Legal 500 Country Comparative Guides - Japan Investing In

2023.11.20

Inventions Made Across Boarders and the Attachment Foreign Filling Restrictions: Conflicts in the Restrictions and How They Are Handled

2023.08.24

Thematic-based: Legal Practice in the Healthcare Business

2022.03.11

A study of the secret patent systems of various countries, and the introduction of the same system in Japan (No.2)(end)

2022.02.14

A study of the secret patent systems of various countries, and the introduction of the same system in Japan (No.1)

2021.12.01

A Detailed Explanation of Economic Partnership Agreements

2021.10.01

Obligation to Conclude Multilateral Treaties in the Field of Intellectual Property through FTA/EPA - Efforts to Strengthen Protection of Rights and to Achieve International Harmonization of Systems -

2021.03.31

Protection of Geographical Indications under the TPP and Japan-EU Economic Partnership Agreement (EPA)

2021.03.26

Selected Intellectual Property Issues under the TPP and Japan-EU EPA

2020.01.01

Dictionary of Contract Terms (Revised Edition)

2019.01.01

Business and IP commitments in Economic Partnership Agreements (EPAs)

2017.05.01

JAPAN Section/Protection and Disclosure of Trade Secrets and Know-How

2015.04.01

The Existence of a “Dispute” and the Prima Facie Test for a Tribunal to Have Jurisdiction

2015.03.01

Handbook on Joint Research and Development Agreement

2015.02.01

Reading of U.S. Supreme Court Cases: Commentary on Intellectual Property and Business Cases in the 21st Century

2014.05.01

Document Production Procedure and the Scope of Privilege in Investment Treaty Arbitration

2012.12.01

Indirect Expropriation, Fair and Equitable Treatment Obligations, and Valuation Standards and Methods of Damages under CAFTA

2011.12.01

The investment treaty arbitration decision finding that (i) the change of tax scheme after the investments and demands to hire a given level of nationals did not constitute a breach of the Fair and Equitable Treatment (FET) obligations and that (ii) a breach of contract by the central bank constituted a breach of the ‘expanded’ FET obligations imported through the MFN clause.

2011.08.01

Dictionary of Contract Terms

2010.09.01

Intellectual Property Commitments in Japan's Economic Partnership Agreements (EPAs)

2010.01.01

Negotiations regarding Intellectual Property in Economic Partnership Agreements (EPAs), [1] - [9]

2007.05.01

Commentary on FTA/EPA Negotiations

2024.09.26

[Report from China] How about a CASE like this?

2024.09.26

Legal Affairs for Chinese Life Sciences and Healthcare No. 22: Shanghai Cosmetics Industry Advertising Compliance Guidelines

2024.09.26

New Developments in the Cross-Border Transfer of Data in Free Trade Zones - Consideration of Cross-Border Transfer of Data in the Tianjin Free Trade Zone Data (Negative List) and Cross-Border Transfer of Data in the Shanghai Free Trade Zone (General Data List) with a focus on the Biomedical Sector

2024.07.24

[Report from China] Comparing Sino-Japanese Court Cases

2024.07.24

Brief Analysis of the Provisional Rules for the Prevention of Unfair Network Competition

2024.06.26

[Report from China] Were they all that precise?

2024.06.26

Chinese Corporate Law in the New Era and Its Impact on Foreign-Invested Enterprises – Part 5: Rights of Minority Shareholders under the Chinese Corporation Law

2024.05.24

[Report from China] Japanese Movies and TV Dramas in China

2024.05.24

Restructuring and Withdrawal of Chinese Subsidiaries (6)- Withdrawal (ii) Dissolution, Liquidation and Bankruptcy

2024.05.24

Chinese Corporate Law in the New Era and Its Impact on Foreign-Invested Enterprises – Part 4: Amendment to the Chinese Corporate Law and Liability of Management

2024.04.24

[Report from China] Transition to a Cash-friendly China

2024.04.24

Restructuring and Withdrawal of Chinese Subsidiaries (5)- Withdrawal (i) Share Assingment

2024.04.24

Chinese Corporate Law in the New Era and Its Impact on Foreign-Invested Enterprises – Part 3: Amendments to the Capitalization System of a Company

2024.04.10

Foreign Filling Restrictions of Major Countries －Mechanisms to Restrict Foreign Filing of Sensitive Inventions－

2024.03.22

[Report from China] Has Deflation Begun? Changing Consumption Styles in China

2024.03.22

Restructuring and Withdrawal of Chinese Subsidiaries (4) - Restructuring (iii) Company Split and Business Transfer

2024.03.22

Chinese Corporate Law in the New Era and Its Impact on Foreign-Invested Enterprises – Part 2: Revisions to the Design of Company Organizations

2024.02.22

[Report from China] Knowing China through Tea

2024.02.22

Restructuring and Withdrawal of Chinese Subsidiaries (3) - Restructuring (ii) Administration Services Company

2024.01.24

[Report from China] Miscellaneous Thoughts in My 12th Year of Living in Shanghai

2024.01.24

Restructuring and Withdrawal of Chinese Subsidiaries (2) - Restructuring (i) Merger

2024.01.24

Legal Affairs for Chinese Life Sciences and Healthcare No. 21: Revision to the Administrative Regulation on Wholesale, Retail, etc., of Pharmaceutical Products (Establishment of the Regulation on Supervision and Administration of Business Management and Quality of Pharmaceutical Products)

2024.01.24

Chinese Corporate Law in the New Era and Its Impact on Foreign-Invested Enterprises – Part 1: The First Major Revision Since 2005 and an Outline Thereof

2023.12.26

[Report from China] Marathons Familiar to the Chinese People

2023.12.26

Restructuring and Withdrawal of Chinese Subsidiaries (1) - Introduction

2023.11.28

[Report from China] Strategy for Eliminate Scalpers in China

2023.11.28

Legal Affairs for Chinese Life Sciences and Healthcare No. 20: Notice on Enhancing the Supervision and Administration of Contract Manufacture of Drug Marketing Authorization Holders (No. 132 of 2023)

2023.11.28

Response to the Risk of Misconduct in Business in China (5) - Changes in the Business Environment in China and Efforts to Maintain Business Health

2023.11.20

Inventions Made Across Boarders and the Attachment Foreign Filling Restrictions: Conflicts in the Restrictions and How They Are Handled

2023.10.27

[Report from China] It Depends on the Way of Presenting Statistics

2023.10.27

Publication of the Draft Revisions to the Product Quality Law of China

2023.09.29

[Report from China] Playing Golf in China

2023.09.29

Response to the Risk of Misconduct in Business in China(4) - Effect of Cross-border Data Regulations of China: Handling of Personal Information or the like in Internal Investigations

2023.08.28

[Report from China] Chinese Ventures with Great Commercial Enthusiasm

2023.08.28

Obligation to Establish a Quality and Safety Management System in China

2023.08.25

[Serial Article/Legal Affairs for Companies Expanding Overseas] [No.5] Security and Business: Conflict of Nations and Regulation of Certain Companies

2023.07.25

Legal Affairs for Chinese Life Sciences and Healthcare No.19: Handling and Transborder Transfer of Human Genetic Resources and Information in Chinese Domestic Clinical Trials and Scientific Research

2023.07.25

[Report from China] China’s University Entrance Examination System (Gaokao /National College Entrance Examination)

2023.05.24

[Report from China] Labor Day after the Zero-COVID Policy

2023.05.24

Legal Affairs for Chinese Life Sciences and Healthcare No.18: Enactment of Regulations on Toothpaste in China

2023.04.26

[Report from China] Chat GPT and China

2023.04.26

China Transborder Regulation of Personal Data (1)

2023.04.26

Response to the Risk of Misconduct in Business in China(3) - Establishment of an Internal Control System and Allocation of Management Resources in a Chinese Subsidiary

2023.03.28

[Report from China] Spring is the Season for Politics

2023.03.28

Legal Affairs for Chinese Life Sciences and Healthcare No.17: Enforcement of the Rules for Responsible Supervision and Management of Quality and Safety Enforcement Entities for Drugs, Cosmetics and Medical Devices

2023.03.28

Response to the Risk of Misconduct in Business in China(2) - Facilitating Information Sharing with Chinese Subsidiaries

2023.02.28

Response to the Risk of Misconduct in Business in China – Focusing on the Response to Signs of Misconduct

2023.02.28

Legal Affairs for Chinese Life Sciences and Healthcare No.16: Rejection of UCB Pharma S.A. and GlaxoSmithKline (Ireland) Limited in the Extraterritorial Off-Site Inspection

2023.02.28

A Commentary on the New Draft Amendment to the “Companies Law” of China – In Comparison with the First Draft Amendment

2023.02.27

China’s Life Science and Healthcare-No.3 Amendment of the Regulations on Cosmetics in China

2023.01.20

[Report from China] Traveling to China Immediately after the Lifting of the “Zero-Covid” Policy

2023.01.20

Legal Affairs for Chinese Life Sciences and Healthcare No.15: System of the Person Responsible for the Production Safety (Safety Officer) of Food and Food-related Products in China

2023.01.20

Labor Issues after Reclassification of the Novel Coronavirus Infectious Disease as a “Category B Infectious Disease Managed under Category B Protocols”

2022.12.28

[Report from China] Reversal of the Policies for the Novel Coronavirus Pandemic

2022.12.28

Labor Issues after Relaxation of the Policies for the Novel Coronavirus Pandemic

2022.11.29

[Report from China] My Experience When China’s Health Code System Indicated a Yellow Code

2022.10.25

[Report from China] The National Congress of the Communist Party of China and the National People’s Congress

2022.10.25

Legal Affairs for Chinese Life Sciences and Healthcare (Part 13) -Chinese Regulations on Labeling and Advertisement for Cosmetics-

2022.10.25

Review of the Draft Amendment to the “Company Act” in China - Revisions to Organizational Structure and the Impact on Japanese Companies -

2022.09.27

[Report from China] National Holidays in China

2022.09.27

Summary of the Amendment to the Chinese Anti-Monopoly Law (2) – Monopoly agreements and abuses of dominant market positions

2022.08.22

Summary of the Amendment to the Chinese Anti-Monopoly Law (1) – Combination of business operators

2022.08.22

[Report from China] Car License Plate Situation in Shanghai

2022.07.26

[Report from China] A Double Whammy with the Inflation and the Weak Yen

2022.07.26

Standard Agreement on the Extraterritorial Transfer of Personal Information

2022.07.04

China’s Life Sciences and Healthcare-No.2 －The Good Vigilance Practice rule in China

2022.07.04

Legal Compliance of Workplace Surveillance in China -From a Personal Information Protection Perspective

2022.06.23

[Report from China] Shanghai After the Lifting of the Lockdown

2022.05.26

[Report from China] Shanghai Lockdown to be Fully Lifted by Mid to Late June

2022.05.26

Legal Affairs for Chinese Life Sciences and Healthcare (Part 10) - Toward the Enforcement of the New Cosmetics GMP

2022.04.27

[Report from China] Lockdown in Shanghai Continues with No End in Sight

2022.04.27

Legal Affairs for Chinese Life Sciences and Healthcare (Part 9) - [Subsidiary Regulations on Administrative Measures for Monitoring of Adverse Reactions to Cosmetics] Overview

2022.04.27

Addressing Legal Issues Relating to the Resurgence of Covid-19 in China - Focusing on Treatment of Employees and Actions toward Trading Counterparties

2022.03.24

[Report from China] Latest on the Novel Coronavirus in China - Will the Government Change its Zero-Covid Policy?

2022.03.24

Legal Affairs for Chinese Life Sciences and Healthcare (Part 8) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the Subsidiary Regulations on Administration Measures for Cosmetics Manufacture and Operation and the GMP for Cosmetics (3)

2022.03.24

Addressing the Bankruptcy or Liquidation Risk of Chinese Trading Counterparties - Key Points of Claim Collection Bearing in Mind the Risk of Corporate Bankruptcy

2022.03.14

A Legal Review of China’s Life Sciences and 2 Healthcare- No.1 －General Introduction and MAH System

2022.03.14

A Few Key Points of the China Personal Information Protection Law

2022.02.21

Legal Affairs for Chinese Life Sciences and Healthcare (Part 7) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the Subsidiary Regulations on Administration Measures for Cosmetics Manufacture and Operation and the GMP for Cosmetics (2)

2022.02.21

[Report from China] Chinese New Year and Beijing Winter Olympic Games

2022.02.21

System and Legislative Framework Relating to Carbon Emission Trading in China

2022.01.21

[Report from China] Ten Years in Shanghai Saw Many Changes

2022.01.21

Legal Affairs for Chinese Life Sciences and Healthcare (Part 5) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the Subsidiary Regulations on Administration Measures for Cosmetics Manufacture and Operation and the GMP for Cosmetics (1)

2022.01.21

Legal Affairs for Chinese Life Sciences and Healthcare (Part 6) - Trial Program for Cross-border E-commerce Retail Import of Drugs in Henan

2022.01.21

China’s Anti-foreign Sanctions Law and Points that Foreign Corporations should Note

2021.12.22

Personal Information Protection Law of China (2) – Processing of Personal Information and Consent by the Data Subject -

2021.12.22

[Report from China] Digital Yuan and Electronic Payment

2021.11.24

Legal Affairs for Chinese Life Sciences and Healthcare (Part 4) – Developments in Amendment of Regulations Concerning Wholesaling/Retailing of Pharmaceutical Products, Etc. (Measures on Supervision and Control of the Drug Business and Usage Quality (Draft for Comment))

2021.11.24

Measures on Security Assessment of Cross-Border Data Transfers (Draft for Comment) - Basic Points to Note -

2021.10.28

Legal Affairs for Chinese Life Sciences and Healthcare (Part 3) – Approaching the implementation of China GVP (Good Pharmacovigilance Practice) (effective from December 1, 2021) (2)

2021.10.28

Personal Information Protection Law of China (1) - Basic Points to Note -

2021.09.30

Legal Affairs for Chinese Life Sciences and Healthcare (Part 2) –Approaching the implementation of China GVP (Good Pharmacovigilance Practice) (effective from December 1, 2021) (1)

2021.09.30

Looking Back on the First 4 Years of the “Network Security Law” in China (Part II) -China's Regulations on Cross-border Transfer of Data, Etc.

2021.08.30

Looking Back on the First 4 Years of the “Network Security Law” (Part I)

2021.08.30

Legal Affairs for Chinese Life Sciences and Healthcare

2019.10.15

Points to Consider Regarding Advertising Expressions when Doing Business in China

2019.05.10

Case Study on Court Judgement in China Regarding Recognition and Enforcement of Foreign or External Arbitral Award

2019.03.22

Building a Compliance System for China-based Affiliates – Mainly on the Aspects of Transactions

2018.12.10

Acts against Unjustifiable Advertisement and Misleading Representations in China

2018.04.24

Case Study on Court Judgment in China Regarding Recognition and Enforcement of Foreign Arbitral Award (14)

2017.12.27

100 Selected Cases in China, Series 250

2017.02.01

Chinese Business Law System

2017.02.01

Chinese Business Law System: Organized by Internal Division and by Situation [Second Edition]

2016.12.01

Property Preservation in China - Provisions of the Supreme People's Court on several issues concerning the handling of property preservation cases by the people's court

2016.02.10

[Theory and Practice on Civil and Commercial Law in China (97)] Structure of Cross-Border E-Commerce with China and Legal Points to Note therein

2015.09.05

[Special Report] Risks Involved in Overseas Business Expansions of Small and Medium-Sized Enterprises, and Countermeasures Therefor _ Focusing on Legal Risks in China, Thailand, Vietnam and Indonesia -

2015.02.01

Supreme People's Court decision on Abuse of Market Dominant Position under China’s Antitrust Law

2014.10.01

Regulations and Countermeasures in Respect of Chinese Monopoly Agreements　-12 Japanese Auto Parts Suppliers are fined 20 Billion Yen

2014.06.01

100 Selected Cases in China (No. 208): An Introduction and Brief Study on the Notice of the Supreme People's Court of PRC on Publishing the Sixth Batch of Guiding Precedents.

2014.06.01

"(4) Part 1: Basic Legal System of lawsuits concerning Intellectual Property Rights in China" (co-authored)

2014.03.01

“Textbook on Chinese Legal Practice - From Entry to Withdrawal”

2013.06.01

Antitrust in the Emerging Economies of Asia: China and Indonesia

2013.05.01

Recent Amendments and Judicial Interpretation of Labor Related Regulations in China: Focusing on Amendments to the Labor Contract Law in China

2013.01.01

Outline and Practical Issues of Title Retention in Sales Contracts in China

2012.06.01

100 Selected Cases in China (No. 184): Case where the act of the managing company of a video-sharing site in providing data storage space to users who upload movies to such site was held to qualify as aiding copyright infringement

2011.10.01

China "Interim Provisions on Assessing the Impact of the Concentration of Business Operators on Competition"

2011.09.01

China "Interim Provisions on Assessing the Impact of the Concentration of Business Operators on Competition" (Draft for Public Comments)

2010.11.01

“The Roles that Banks Can Play in their Clients' Expansion in China”

2009.04.01

Global Intellectual Property Strategies for Companies Doing Business in China

2009.04.01

Withdrawal by Transfer of Equity Interest

2006.11.01

The Introduction of the Draft Antitrust Law of China and the Risk for Foreign Enterprises

2006.04.01

Guide to International Legal Practice (1) to (11)

2023.08.25

[Serial Article/Legal Affairs for Companies Expanding Overseas] [No.5] Security and Business: Conflict of Nations and Regulation of Certain Companies

2021.08.24

Global Legal Insights to: Pricing & Reimbursement 2021（Fourth Edition） Japan Chapter

2020.08.19

Global Legal Insights to: Pricing & Reimbursement 2020（Third Edition） Japan Chapter

2019.12.13

The Integral Resort (IR) Business has Started - Matters to Note when Entering Into such Business -

2019.08.30

Global Legal Insights to: Pricing & Reimbursement 2019（Second Edition） Japan Chapter

2018.07.24

Japanese IR (integrated resort) business has finally started

2023.11.20

Inventions Made Across Boarders and the Attachment Foreign Filling Restrictions: Conflicts in the Restrictions and How They Are Handled

2023.08.25

[Serial Article/Legal Affairs for Companies Expanding Overseas] [No.5] Security and Business: Conflict of Nations and Regulation of Certain Companies

2022.10.03

Economic Sanction Against Russia and Others - U.S. Export Control Regulations

2022.07.01

Economic Sanctions Against Russia and Other Countries - Measures to Prohibit Export and Others

2022.03.11

A study of the secret patent systems of various countries, and the introduction of the same system in Japan (No.2)(end)

2022.02.14

A study of the secret patent systems of various countries, and the introduction of the same system in Japan (No.1)

2022.01.21

China’s Anti-foreign Sanctions Law and Points that Foreign Corporations should Note

2021.12.01

A Detailed Explanation of Economic Partnership Agreements

2021.10.01

Obligation to Conclude Multilateral Treaties in the Field of Intellectual Property through FTA/EPA - Efforts to Strengthen Protection of Rights and to Achieve International Harmonization of Systems -

2021.03.31

Protection of Geographical Indications under the TPP and Japan-EU Economic Partnership Agreement (EPA)

2019.12.20

International Legal Practice

2019.01.01

Business and IP commitments in Economic Partnership Agreements (EPAs)

2017.09.01

”Tightening of Export Restrictions under the Amended Foreign Exchange and Foreign Trade Act,”

2017.06.01

WTO Case Review 2016 "European Communities – Definitive Anti-Dumping Measures on Certain Iron or Steel Fasteners from China – Recourse to Article 21.5 of the DSU by China (WT/DS397/RW, WD/DS397/AB/RW）"

2017.05.15

Latest WTO Case Law Analysis on Trade Remedies No.23: Permissibility of Disregarding Costs in Exporters' Records in Constructing Normal Value

2016.12.15

Web Commentary on TPP "2.4 National Treatment and Market Access for Goods (Agriculture)"

2016.11.29

Web Commentary on TPP "2.2　National Treatment and Market Access for Goods (Tarrif)"

2016.10.07

Web Commentary on TPP "4　Textile and Apparel Goods"

2016.09.26

Web Commentary on TPP "3　Rules of Origin and Origin Procedures"

2016.09.20

Web Commentary on TPP "22　Competitiveness and Business Facilitation"

2016.09.20

Web Commentary on TPP "24 Small and Medium-Sized Enterprises"

2016.07.01

”The Recent Trends in Tax-Related Problems in India and Indonesia,”

2016.02.01

"M&A and related trade issues based on the TPP,"

2015.11.01

"Responsibilities of Attorneys in Trade and Export Control,"

2012.09.01

"Latest Situation of Anti-Dumping Tariffs as Seen by Companies - Including Measures for Imposition of Tariffs Abroad"

2010.09.01

Intellectual Property Commitments in Japan's Economic Partnership Agreements (EPAs)

2007.05.01

Commentary on FTA/EPA Negotiations

2005.03.01

"Increasingly Tightening Insider Trading Regulations,"

2024.10.01

Response to Human Rights and Environmental Due Diligence required with the Implementation of CSDDD　

2024.03.29

Updates on the LGBTQ+ Status in Japan and Duties of Companies Related Thereto

2023.10.02

Ministry of Economy, Trade and Industry Transgender Case and the Scope of the Judgment Thereof

2023.10.02

Enhancement of Human Rights Due Diligence based on Contract Clauses – Implementation Thereof in the “Upstream” and “Downstream” of Supply Chains

2023.08.25

[Serial Article/Legal Affairs for Companies Expanding Overseas] [No.5] Security and Business: Conflict of Nations and Regulation of Certain Companies

2024.04.10

Foreign Filling Restrictions of Major Countries －Mechanisms to Restrict Foreign Filing of Sensitive Inventions－

2023.12.25

[Serial Article/Legal Affairs for Companies Expanding Overseas] [No.9] Climate Change and Corporate Litigation Risk

2023.11.20

Inventions Made Across Boarders and the Attachment Foreign Filling Restrictions: Conflicts in the Restrictions and How They Are Handled

2023.10.02

Cyberattacks, cybersecurity, and economic security…? Take a Pause to Consider them

2023.08.25

[Serial Article/Legal Affairs for Companies Expanding Overseas] [No.5] Security and Business: Conflict of Nations and Regulation of Certain Companies

2023.01.13

[US Export Administration Regulations (EAR)] Expansion of the Extraterritorial Coverage of the US EAR (Direct Product Rule)

2022.03.01

Summary of Countermeasures for Counterfeit Products in the US

2021.04.01

Patent Enforcement Practices Before, During and After Patent Litigation Proceedings in Japan – A Comparative Analysis with Germany and the United States –

2021.03.31

Protection of Geographical Indications under the TPP and Japan-EU Economic Partnership Agreement (EPA)

2021.01.01

The Ways of Limiting Injunctive Relief in Patent Infringement Litigation and their Effects – Current Japanese Practices and Suggestions for their Future Improvements, based on the Recent Trends in Germany and the United States –

2020.07.29

Elpida Memory Corporate Reorganization Proceedings – International Bankruptcy Case of a Semiconductor Memory Manufacturer that Obtained a Decision of Recognition of a Reorganization Plan [in Japan]

2019.10.21

DOJ Dawn Raid Preparation and Response Checklist (Part 2) ~Contemplating Compliance Programs for Global Corporations based on Overseas Practice of Competition Laws~

2019.09.21

DOJ Dawn Raid Preparation and Response Checklist (Part 1) ~Contemplating Compliance Programs for Global Corporations based on Overseas Practice of Competition Laws~

2019.07.09

Various Aspects of the US Bankruptcy Law #5 –Venue for Chapter 11 filings

2019.03.01

Schmidt's Deodorant Company (Natural Deodorant Products), Report #6127, NAD/CARU Case Reports (10/27/2017) - A Case Study where Advertising Claims based on General Customers' Reviews were Found Inappropriate in the US -

2017.11.27

Lecture on Practices of the U.S. Antitrust Laws

2015.02.01

Reading of U.S. Supreme Court Cases: Commentary on Intellectual Property and Business Cases in the 21st Century

2014.05.01

Document Production Procedure and the Scope of Privilege in Investment Treaty Arbitration

2008.12.01

"Emergency Measures to Rescue Financial Institutions in the US,"

2008.11.01

"Formulation of Financial Institution Rescue Measures in the United States"

2006.04.01

Guide to International Legal Practice (1) to (11)

2003.01.01

"Q&A on Reorganization of US Branches and Subsidiaries - Procedures, Tax/Legal Issues under Local Legislation,"

2002.10.01

"US-Japan Comparison - Tax and Legal Matters of Financial Instruments,"

2002.09.01

"Tax Q&A on Corporate Restructuring Across Japan and the US"

2024.10.01

Response to Human Rights and Environmental Due Diligence required with the Implementation of CSDDD　

2024.02.02

Understanding the Basics: Q&A on the Legal Practice on ESG and Sustainability

2024.01.12

International Trends in Business and Human Rights and the Responses of Japanese Companies

2023.12.25

[Serial Article/Legal Affairs for Companies Expanding Overseas] [No.9] Climate Change and Corporate Litigation Risk

2023.08.25

[Serial Article/Legal Affairs for Companies Expanding Overseas] [No.5] Security and Business: Conflict of Nations and Regulation of Certain Companies

2023.06.23

Diversity & Inclusion: LGBTQ+ Status in Japan

2023.06.23

Business and Human Rights in Japan

2023.05.11

The Legal 500 Country Comparative Guides Japan Environmental, Social and Governance

2023.05.09

Measures needed by Japanese companies in the face of greenwashing and the anti-ESG movement – Verification of important ESG factors in legal DD during M&A and subsidiary management

2023.02.28

Impact of the Enactment of the German Act, "Act on Corporate Due Diligence in Supply Chains," on Japanese Companies

2022.11.25

Implementation of Human Rights Due Diligence in Financial Institutions (Volume 2) - In Light of the Government Guidelines and International Trends -

2022.11.18

New Trends in ESG and M&A /[Part 6]Trends in Diversity that are Crucial for Management Strategy -- Key Issues on Labor Environment, D&I and LGBTQ

2022.11.14

Implementation of Human Rights Due Diligence in Financial Institutions (Volume 1) - In Light of the Government Guidelines and International Trends -

2022.09.29

Commentary on the "Guidelines for Respecting Human Rights in Responsible Supply Chains, etc." and its Impact on Corporate Practices

2022.09.26

New Trends in ESG and M&A / Environment and Litigation- Focusing on the rapid increase in Climate Change Litigation around the world

2022.09.08

New Trends in ESG and M&A / the Latest Trends in Business and Human Rights and Practice